journal
https://read.qxmd.com/read/38527461/effects-of-onabotulinum-toxin-a-injection-on-sexual-function-in-women-with-refractory-interstitial-cystitis-bladder-pain-syndrome-a-prospective-study
#1
JOURNAL ARTICLE
Murat Can Karaburun, Eralp Kubilay, Derya Öztuna, Mehmet İlker Gökçe, Evren Süer, Ömer Gülpınar
OBJECTIVES: To determine the effect of intravesical onabotulinum toxin-A (BoNT-A) treatment on sexual functions in female patients with refractory interstitial cystitis/bladder pain syndrome (IC/BPS). METHODS: Female patients with IC/BPS refractory to previous treatments were included in the study between January 2020 and April 2022. Patients were treated with the trigone-sparing injection (Group 1) or trigone-included injection (Group 2) techniques. 100 Units of BoNT-A was applied submucosally on 20 different points...
March 2024: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/38356345/correction-to-predictive-factors-for-the-success-of-trial-without-catheter-for-men-with-urinary-retention
#2
(no author information available yet)
No abstract text is available yet for this article.
March 2024: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/38282138/comparison-between-combination-of-tamsulosin-and-pentoxifylline-versus-tamsulosin-alone-in-the-treatment-of-lower-urinary-tract-symptoms-due-to-benign-prostate-hyperplasia-a-preliminary-study
#3
JOURNAL ARTICLE
Mehdi Shirazi, Alireza Dehghanmanshadi, Soroush Sadr, Zahra Jahanabadi
BACKGROUND: In older adults, bladder outlet obstruction (BOO) is prevalent, primarily due to benign prostatic hyperplasia (BPH). These patients' lower urinary tract symptoms can be treated surgically and with medical therapy. Compared to standard treatment with tamsulosin, Pentoxifylline, a phosphodiesterase inhibitor, could benefit patients with BOO due to its properties on microcirculatory blood flow and oxygenation of ischemic tissues. Hence, this trial intended to study the efficacy of Pentoxifylline combined with tamsulosin in treating BOO patients...
January 2024: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37987028/multimodal-therapies-and-strategies-for-the-treatment-of-interstitial-cystitis-bladder-pain-syndrome-in-taiwan
#4
REVIEW
Wan-Ru Yu, Hann-Chorng Kuo
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease characterized by bladder pain, frequency, and nocturia. The most common pathologies include chronic inflammation and bladder urothelium dysfunction. According to the bladder condition with or without Hunner's lesions, IC/BPS can be divided into "IC" in patients with Hunner's lesion (HIC) and "BPS" in those without Hunner's lesion (NHIC). Previous studies have reported greater central sensitization and interorgan cross-talk in patients with NHIC...
January 2024: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37984074/longitudinal-deterioration-in-lower-urinary-tract-symptoms-after-artificial-urinary-sphincter-implantation-in-patients-with-a-history-of-pelvic-radiation-therapy
#5
JOURNAL ARTICLE
Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii
OBJECTIVES: To evaluate longitudinal changes in lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation in patients undergoing radiation therapy (RT) in comparison to those in non-irradiated patients. METHODS: This retrospective study included 20 and 51 patients with and without a history of pelvic RT (RT and non-RT group, respectively) who were treated with primary AUS implantation for post-radical prostatectomy incontinence between 2010 and 2020...
November 20, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37750459/optimal-endoscopic-treatment-and-partial-cystectomy-with-or-without-bladder-augmentation-for-hunner-type-interstitial-cystitis
#6
REVIEW
Jiwoong Yu, Chung Un Lee, Kyu-Sung Lee, Kwang Jin Ko
Interstitial cystitis/bladder pain syndrome (IC/BPS) presents a significant challenge for urologists in terms of management, owing to its chronic nature and adverse impact on patient quality of life. Given the potential distinction between two disease entities within IC/BPS, namely Hunner-type IC and BPS without Hunner lesion, there is a need for an optimal therapeutic approach that focuses on the bladder lesions in Hunner-type IC. In cases where Hunner lesions are observed, complete transurethral ablation of these lesions should be prioritized as the initial intervention, as it has demonstrated effectiveness in symptom control...
November 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37702275/intravesical-injections-of-autologous-platelet-rich-plasma-for-the-treatment-of-refractory-interstitial-cystitis
#7
REVIEW
Hann-Chorng Kuo
The urothelium acts as a barrier for the urinary bladder that prevents the influx of urinary toxic substances, electrolytes, urea nitrogen, and pathogens into the circulation. Acute or chronic inflammation of the urinary bladder may impair the regenerative function of urothelial cells and thus urothelial cell differentiation. In an inflamed bladder wall, mature apical cells are defective, resulting in impaired barrier function and thus increased urothelial permeability. This is considered to be the potential mechanism of the symptom trigger in patients with interstitial cystitis/bladder pain syndrome (IC/BPS)...
November 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37866821/association-between-voiding-lower-urinary-tract-symptoms-and-findings-on-dynamic-magnetic-resonance-imaging-with-regard-to-pelvic-organs-and-their-supportive-structures
#8
JOURNAL ARTICLE
Shoutarou Watanabe, Kurenai Kinno, Yasuharu Takeuchi, Yoshitomo Sawada, Noritoshi Sekido
OBJECTIVES: Pelvic organ prolapse (POP) causes voiding lower urinary tract symptoms (vLUTS). In the present study, we investigated the association between vLUTS and pelvic organ mobility (POM), including relevant supportive structures, on dynamic magnetic resonance imaging (dMRI). METHODS: We included 118 patients who had POP of stage II or less before straining and stage III or more when straining during dMRI. The presence of vLUTS and overactive bladder (OAB) was determined by a voiding subscore of the International Prostate Symptom Score (vIPSS) ≥5 and the OAB symptom score, respectively...
October 22, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37721189/effects-of-a-new-selective-%C3%AE-3-adrenoceptor-agonist-vibegron-on-bladder-and-urethral-function-in-a-rat-model-of-parkinson-s-disease
#9
JOURNAL ARTICLE
Mio Togo, Takeya Kitta, Hiroki Chiba, Madoka Higuchi, Naohisa Kusakabe, Mifuka Ouchi, Yui Abe-Takahashi, Hidehiro Kakizaki, Nobuo Shinohara
OBJECTIVES: Parkinson's disease caused by the loss of dopaminergic neurons induces not only motor dysfunction but also lower urinary tract dysfunction. Patients with Parkinson's disease have recently been reported to experience both urge urinary incontinence (overactive bladder) and stress urinary incontinence, the latter of which occurs when the pressure of the bladder exceeds that of the urethra. Vibegron is a highly selective novel β3 -adrenoceptor agonist approved for the treatment of overactive bladder...
September 18, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37700527/number-of-patients-with-interstitial-cystitis-bladder-pain-syndrome-seen-before-versus-during-the-covid-19-pandemic-at-an-academic-urban-multisite-urogynecology-practice
#10
JOURNAL ARTICLE
Tahireh Markert, Alexa Courtepatte, Subrina Farah, Jeannine M Miranne
OBJECTIVES: Little is known about the impact of the COVID-19 pandemic on interstitial cystitis/bladder pain syndrome (IC/BPS). We aim to compare the number of newly diagnosed IC/BPS cases and number of patients with flares prior to and during the pandemic. METHODS: We conducted a retrospective cohort study of women ≥18 years who were diagnosed with or treated for IC/BPS between March 2019 and March 2021 at an academic, urban, multisite urogynecology practice...
September 12, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37688290/serum-anandamide-and-lipids-associated-with-linoleic-acid-can-distinguish-interstitial-cystitis-bladder-pain-syndrome-from-overactive-bladder-an-exploratory-study
#11
JOURNAL ARTICLE
Kazumasa Torimoto, Tomohiro Ueda, Daisuke Gotoh, Kuniyuki Kano, Makito Miyake, Yasushi Nakai, Shunta Hori, Yosuke Morizawa, Kenta Onishi, Takuto Shimizu, Mitsuru Tomizawa, Junken Aoki, Kiyohide Fujimoto
OBJECTIVES: Diagnosing interstitial cystitis/bladder pain syndrome presents a major challenge because it relies on subjective symptoms and empirical cystoscopic findings. A practical biomarker should discriminate diseases that cause increased urinary frequency, particularly overactive bladder. Therefore, we aimed to identify blood biomarkers that can discriminate between interstitial cystitis/bladder pain syndrome and overactive bladder. METHODS: We enrolled patients with Hunner-type interstitial cystitis (n = 20), bladder pain syndrome (n = 20), and overactive bladder (n = 20) and without lower urinary tract symptoms (controls, n = 15) at Ueda Clinic and Nara Medical University Hospital from February 2020 to August 2021...
September 8, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37232068/risk-factors-for-a-failed-trial-without-catheter-following-convective-water-vapor-thermal-therapy-cwvtt-rezum
#12
JOURNAL ARTICLE
Michael D Felice, Kaylin Kim, Sarang Janakiraman, Gaurav Pahouja, William Adams, Erin Fruth, Ahmer Farooq, Kevin T McVary
OBJECTIVES: Convective water vapor thermal therapy (CWVTT-Rezum) is a minimally invasive surgical therapy that is being increasingly utilized for bladder outlet obstruction. Most patients leave the site of care with a Foley catheter in place for a mean reported duration of 3-4 days. A minority of men will fail their trial without catheter (TWOC). We aim to identify the frequency of TWOC failure following CWVTT and its associated risk factors. METHODS: Patients who underwent CWVTT at a single institution from October 2018 to May 2021 were retrospectively identified and pertinent data extracted...
September 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37649457/the-expression-and-distribution-of-tacan-in-human-and-rat-bladders
#13
JOURNAL ARTICLE
Qudong Lu, Qian Liu, Shiwei Chen, Jiaolian Wang, Yongjie Chen, Bishao Sun, Zhenxing Yang, Huan Feng, Shanhong Yi, Wei Chen, Jingzhen Zhu
OBJECTIVES: A lot of ion channels participate in the regulation of bladder function. TACAN, a new mechanosensitive ion channel, was first discovered in 2020. TACAN has been found to be expressed in many tissues, such as the dorsal root ganglia (DRG) and adipose tissue. However, it is unclear whether or not TACAN is expressed in the bladder. In this work, we decided to study the expression and distribution of TACAN in human and rat bladders. Meanwhile, the expression of TACAN in the rat model of interstitial cystitis/bladder pain syndrome (IC/BPS) was studied...
August 31, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37614063/efficacy-of-cognitive-behavioral-therapy-using-self-check-sheet-for-patients-with-nocturia-in-real-world-clinical-practice
#14
JOURNAL ARTICLE
Yuki Kyoda, Koji Ichihara, Ippei Muranaka, Yasuyuki Sakai, Makoto Nakamura, Nobuo Shinkai, Nodoka Kozen, Wakako Yorozuya, Daichi Morooka, Kazutaka Maruo, Kimihito Tachikawa, Kosuke Shibamori, Seisuke Nofuji, Keiko Fujino, Shuichi Kato, Takashi Yoshida, Tetsuya Shindo, Takeshi Maehana, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori
OBJECTIVES: We previously demonstrated the efficacy of cognitive behavioral therapy (CBT) using a self-check sheet for patients with nocturia in a randomized controlled study. Additionally, we investigated the efficacy of the intervention in real-world clinical practice. METHODS: Two hundred forty-three outpatients with complaint of nocturia who practiced CBT for 4 weeks using a self-check sheet were included in this trial, which took place from April 2021 to March 2022 in 20 institutions...
August 23, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37614060/uroflowmetry-parameters-in-healthy-children-between-5-and-15%C3%A2-years-old
#15
JOURNAL ARTICLE
Yeşim Demirkıran Öztürk, Ahmet Taner Elmas, Yılmaz Tabel
OBJECTIVES: Uroflowmetry (UFM) is the first-line noninvasive screening test employed in the diagnosis of lower urinary tract dysfunction (LUTD). The purpose of this study was to determine normal UFM values in healthy Turkish children among our local population. METHODS: A total of 100 healthy girls and 62 healthy boys aged 5-15 years, who applied to İnönü University Turgut Özal Medical Center Pediatrics Polyclinic between February 2021 and January 2022, were included in the present study...
August 23, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37464971/correction-to-hip-dysfunction-related-urinary-incontinence-and-total-hip-arthroplasty-with-the-direct-lateral-approach
#16
(no author information available yet)
No abstract text is available yet for this article.
July 19, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37448183/utilization-and-safety-of-telemedicine-for-pediatric-lower-urinary-tract-symptoms-before-and-during-the-covid-19-pandemic
#17
JOURNAL ARTICLE
Abby L Chen, Stav Spinzi, Gunjan Agrawal, Kathleen M Kan
OBJECTIVES: Telemedicine for pediatric lower urinary tract symptoms (pLUTS) is a relatively new mode of delivering bladder health education with scant evidence supporting current practice. We aim to examine the safety of pLUTS-related telemedicine visits surrounding the COVID-19 pandemic. METHODS: We conducted a retrospective cohort study of new pLUTS referral diagnoses to our institution's pediatric urology clinics. Demographics, wait times, and referral diagnoses were captured and compared before and after March 2020 using χ2 /Fisher exact tests and t-tests...
July 13, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37190924/efficacy-and-safety-of-the-rezum-system-for-the-treatment-of-catheter-dependent-urinary-retention-three-year-real-world-outcomes-in-a-multimorbid-multiethnic-population
#18
JOURNAL ARTICLE
Mustufa Babar, Zaki Masoud, Kevin Labagnara, Justin Loloi, Rahman Sayed, Sandeep Singh, Kevin Tang, Umar Syed, Michael Ciatto
OBJECTIVES: To evaluate the long-term real-world efficacy and safety of Rezum for the treatment of catheter-dependent urinary retention in a multimorbid, multiethnic population. METHODS: A single-office, retrospective study was conducted on patients treated with Rezum between 2017 and 2019. Patients were included if they had catheter-dependent urinary retention prior to treatment and at least one follow-up within 36 months postoperatively. Patient demographics, procedural characteristics, adverse events (AEs), and outcome measures, including benign prostate hyperplasia (BPH) medication usage and postvoid residual (PVR), were collected at 3, 6, 12, and/or 36 months postoperatively...
July 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37376761/incidence-and-predictors-of-urinary-incontinence-rates-post-holmium-laser-enucleation-of-prostate
#19
JOURNAL ARTICLE
Mohamed Elsaqa, Yu Zhang, Harry Papaconstantinou, Marawan M El Tayeb
INTRODUCTION: One of the main adverse outcomes following Holmium laser enucleation of the prostate (HoLEP) is the development of transient de novo urinary incontinence (UI). We aimed to evaluate the correlation of multiple risk factors to UI rates post-HoLEP. METHODS: A review of prospectively maintained 7 year database for HoLEP patients in a single center was performed. UI data at 6 week, 3 month, and 1 year follow-up intervals were assessed with bivariate and multivariate analysis of multiple potential risk factors...
June 27, 2023: Lower Urinary Tract Symptoms
https://read.qxmd.com/read/37365141/urinary-incontinence-in-the-postpartum-1-year-period-its-prevalence-and-effect-on-psychosocial-status-of-women
#20
JOURNAL ARTICLE
Gulennur Suar, Feride Cevik, Nurgul Simal Yavuz, Nebahat Ozerdogan
OBJECTIVES: In this study, it was aimed to determine the prevalence and effect of urinary incontinence in the postpartum 1 year period on psychosocial status of women. METHODS: This study with a cross-sectional and descriptive design was conducted between 01.10.2021 and 01.04.2022. There were 406 women in the postpartum 8 weeks to 1 year period who participated in the study. The data were collected through Identifying Information Form, Edinburgh Postnatal Depression Scale, and Nottingham Health Profile...
June 26, 2023: Lower Urinary Tract Symptoms
journal
journal
42405
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.